These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3035743)

  • 1. Leukotrienes do not modify the effects of PAF on human platelet aggregation.
    Filep J; Földes-Filep E
    Thromb Res; 1987 Mar; 45(6):865-70. PubMed ID: 3035743
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets.
    Dahl ML
    Int Arch Allergy Appl Immunol; 1985; 76(2):145-50. PubMed ID: 2981776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
    Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    Ford-Hutchinson AW
    Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of arachidonic acid metabolites and platelet activating factor and mechanism of action in hypersensitivity reactions.
    Jancar S; Braquet P; Sirois P
    Braz J Med Biol Res; 1987; 20(5):487-94. PubMed ID: 2838117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
    Hopkins NK; Schaub RG; Gorman RR
    Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
    Altman R; Scazziota A; Rouvier J; Cacchione R
    Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between chemotactic peptide and platelet-activating factor in stimulating thromboxane B2 and leukotriene B4 biosynthesis in human neutrophils.
    Tanizawa H; Tai HH
    Biochem Pharmacol; 1989 Aug; 38(15):2559-63. PubMed ID: 2547385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents.
    Del Maschio A; Evangelista V; Rajtar G; Chen ZM; Cerletti C; De Gaetano G
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H870-9. PubMed ID: 2156456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of econazole on the release of thromboxanes.
    Jancar S; Teixeira CF; de Lima WT; Fujimura AY; Sirois P
    Agents Actions; 1991 Nov; 34(3-4):387-92. PubMed ID: 1667245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis.
    Goetzl EJ; Brindley LL; Goldman DW
    Immunology; 1983 Sep; 50(1):35-41. PubMed ID: 6193056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dauricine and anisodamine on LTs and PAF induced DNA synthesis in bovine anterior cerebral arterial smooth muscle cells.
    Zeng GQ; Ju DW; Sun DX; Rui YC
    Yao Xue Xue Bao; 1992; 27(8):561-5. PubMed ID: 1336297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the vasoactive effects of leukotrienes with thromboxane mimic in the perfused human placenta.
    Thorp JA; Walsh SW; Brath PC
    Am J Obstet Gynecol; 1988 Dec; 159(6):1376-80. PubMed ID: 2849879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF-induced platelet aggregation and TXB2 formation.
    Küster LJ; Frölich JC
    Thromb Res; 1989 Jan; 53(1):89-90. PubMed ID: 2922704
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of leukotrienes and PAF-acether electrophysiological activity of the rat retina.
    Doly M; Braquet P; Bonhomme B; Meyniel G
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():201-8. PubMed ID: 3022310
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
    Wallace JL; MacNaughton WK
    Eur J Pharmacol; 1988 Jun; 151(1):43-50. PubMed ID: 2843390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.